1. Home
  2. ALRS vs RGNX Comparison

ALRS vs RGNX Comparison

Compare ALRS & RGNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Alerus Financial Corporation

ALRS

Alerus Financial Corporation

N/A

Current Price

$31.71

Market Cap

831.8M

Sector

Finance

ML Signal

N/A

Logo REGENXBIO Inc.

RGNX

REGENXBIO Inc.

N/A

Current Price

$7.43

Market Cap

793.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ALRS
RGNX
Founded
1879
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
831.8M
793.5M
IPO Year
2019
2015

Fundamental Metrics

Financial Performance
Metric
ALRS
RGNX
Price
$31.71
$7.43
Analyst Decision
Hold
Buy
Analyst Count
5
11
Target Price
★ $35.40
$23.73
AVG Volume (30 Days)
121.5K
★ 1.0M
Earning Date
10-29-2026
11-05-2026
Dividend Yield
★ 2.79%
N/A
EPS Growth
N/A
★ 18.08
EPS
★ 1.70
N/A
Revenue
N/A
★ $10,393,000.00
Revenue This Year
$5.94
N/A
Revenue Next Year
$2.67
$29.31
P/E Ratio
$18.65
★ N/A
Revenue Growth
N/A
★ 126.48
52 Week Low
$20.31
$5.46
52 Week High
$34.40
$16.19

Technical Indicators

Market Signals
Indicator
ALRS
RGNX
Relative Strength Index (RSI) 32.82 38.23
Support Level $30.13 $7.12
Resistance Level $31.86 $11.43
Average True Range (ATR) 0.67 0.44
MACD -0.15 0.02
Stochastic Oscillator 0.00 29.14

Price Performance

Historical Comparison
ALRS
RGNX

About ALRS Alerus Financial Corporation

Alerus Financial Corp is a financial holding company registered in the United States. The company operates in four segments: Banking, Retirement & Benefit Services, Wealth Management, and others. The company provides various banking services such as checking, debit cards, savings, current deposits, loans and advances, online banking, mobile banking, private banking, payment solutions, and other business products. Additionally, the company provides mortgage loans, retirement planning solutions, individual retirement accounts, retirement plan advisory services and wealth management services, including retirement plans, and fiduciary services. The company's revenue mainly consists of interest income, commission, management fees, and other income.

About RGNX REGENXBIO Inc.

Regenxbio Inc is a clinical-stage biotechnology company focused on the development of gene therapy treatments. Its product candidates are designed to deliver genes to cells to address genetic defects or enable the production of therapeutic proteins. The company is developing a pipeline of investigational gene therapy treatments using its NAV Technology Platform based on adeno-associated virus (AAV) vectors. Its internal research and development programs are focused on therapies for retinal, neuromuscular, and neurodegenerative diseases.

Share on Social Networks: